DarioHealth (DRIO) Reports Q2 Loss of $0.43 on Revenues of $1.21M

DarioHealth (NASDAQ: DRIO) reported Q2 EPS of ($0.43). Revenue for the quarter came in at $1.21 million, versus $0 reported last year.

Second Quarter Highlights

• Record revenues of $1,210,000, increased 81% compared to the second quarter of 2016
• Sequential quarterly revenue growth of 20% over the first quarter of 2017
• 75% of quarterly revenues derived from test strips and other consumables
• Gross profit of 29.8% as a result of increase in quantities sold and higher average sale prices together with an increase in consumable sales
• More Than 8,000 Dario™ Blood Glucose Monitoring System devices sold in the U.S.; reaching cumulative sales of more than 33,000 devices in the U.S.
• Cash burn decreased by $338,000 or 11% compared to the first quarter of 2017

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
• Impinj (PI) Tops Q1 EPS by 11c, provides guidance
• Newmarket (NEU) Reports Q1 EPS of $11.23